Skip to Content
Home > Patients & Visitors > Health Library > Total Lymphoid Irradiation for Multiple Sclerosis
Total lymphoid irradiation uses radiation to limit the production of
white blood cells (lymphocytes). These cells help the
body's immune system destroy foreign cells and fight infection. The treatment
was first developed to treat
Hodgkin's lymphoma, a form of cancer.
In theory, total lymphoid irradiation may help prevent progression of
multiple sclerosis (MS) by limiting the production of lymphocytes and thus limiting the activity of
the immune system. The results of studies done so far have failed to show any
Total lymphoid irradiation remains an experimental treatment for MS.
The treatment may be toxic and potentially dangerous and typically is not
Side effects of this treatment may include:
ByHealthwise StaffPrimary Medical ReviewerAdam Husney, MD - Family MedicineAnne C. Poinier, MD - Internal MedicineSpecialist Medical ReviewerBarrie J. Hurwitz, MD - Neurology
Current as ofFebruary 20, 2015
Current as of:
February 20, 2015
Adam Husney, MD - Family Medicine & Anne C. Poinier, MD - Internal Medicine & Barrie J. Hurwitz, MD - Neurology
How this information was developed to help you make better health decisions.
To learn more, visit Healthwise.org
© 1995-2015 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Feeling under the weather?
Use our interactive symptom checker to evaluate your symptoms and determine appropriate action or treatment.
Our interactive Decision Points guide you through making key health decisions by combining medical information with your personal information.
You'll find Decision Points to help you answer questions about:
Get started learning more about your health!
Our Interactive Tools can help you make smart decisions for a healthier life. You'll find personal calculators and tools for health and fitness, lifestyle checkups, and pregnancy.
Send Us Your Feedback
North Kansas City Hospital.